1. Home
  2. DFDV vs ACOG Comparison

DFDV vs ACOG Comparison

Compare DFDV & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DFDV

DeFi Development Corp.

HOLD

Current Price

$3.01

Market Cap

132.1M

Sector

Finance

ML Signal

HOLD

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

HOLD

Current Price

$6.17

Market Cap

110.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
DFDV
ACOG
Founded
2018
2000
Country
United States
Canada
Employees
16
57
Industry
Finance: Consumer Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
132.1M
110.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DFDV
ACOG
Price
$3.01
$6.17
Analyst Decision
Buy
Strong Buy
Analyst Count
1
2
Target Price
$45.00
$16.00
AVG Volume (30 Days)
857.9K
31.2K
Earning Date
05-13-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$32.58
$139.22
Revenue Next Year
$23.65
$134.48
P/E Ratio
$0.90
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.93
$4.50
52 Week High
$33.75
$10.88

Technical Indicators

Market Signals
Indicator
DFDV
ACOG
Relative Strength Index (RSI) 28.72 47.63
Support Level N/A $5.70
Resistance Level $5.22 $6.34
Average True Range (ATR) 0.32 0.32
MACD -0.16 0.03
Stochastic Oscillator 2.25 48.28

Price Performance

Historical Comparison
DFDV
ACOG

About DFDV DeFi Development Corp.

DeFi Development Corp is a U.S. company committed to building its treasury around Solana (SOL), a fast-growing blockchain infrastructure platform. This equity delivers shareholders tangible exposure to SOL price movement and staking rewards, making the firm a proxy for the Solana ecosystem. The treasury extends to running its own validator infrastructure, allowing DFDV to actively participate in and benefit from the Solana network expansion. The firm has two segments: Digital Asset Treasury ("Treasury") and Real Estate Platform ("Real Estate"). The company generates the majority of its revenue from the Treasury segment.

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: